Artesunate Amivas Europska Unija - hrvatski - EMA (European Medicines Agency)

artesunate amivas

amivas ireland ltd - artesunate - malarija - antiprotozoals - artesunate amivas is indicated for the initial treatment of severe malaria in adults and children. treba uzeti u obzir formalne preporuke za odgovarajuće korištenje противомалярийных posrednika.

Eurartesim Europska Unija - hrvatski - EMA (European Medicines Agency)

eurartesim

alfasigma s.p.a. - piperaquine tetraphosphate, artenimol - malarija - antiprotozoals - eurartesim je indiciran za liječenje nekompliciranog plasmodium falciparum malarije kod odraslih, djece i dojenčadi 6 mjeseci i više i težine 5 kg ili više. treba uzeti u obzir formalne preporuke za odgovarajuće korištenje противомалярийных posrednika.

Klimicin 150 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

klimicin 150 mg tvrde kapsule

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - klindamicinklorid - kapsula, tvrda - 150 mg - urbroj: jedna tvrda kapsula sadrži 150 mg klindamicina u obliku klindamicinklorida

Klimicin 300 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

klimicin 300 mg tvrde kapsule

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - klindamicinklorid - kapsula, tvrda - 300 mg - urbroj: jedna tvrda kapsula sadrži 300 mg klindamicina u obliku klindamicinklorida

Klimicin 300 mg/2 ml otopina za injekciju/infuziju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

klimicin 300 mg/2 ml otopina za injekciju/infuziju

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - klindamicinfosfat - otopina za injekciju / infuziju - 300 mg/2 ml - urbroj: svaka ampula (2 ml) otopine za injekciju/infuziju sadrži 300 mg klindamicina u obliku klindamicinfosfata

Pirfenidone Viatris Europska Unija - hrvatski - EMA (European Medicines Agency)

pirfenidone viatris

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imunosupresivi - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Dapagliflozin Viatris Europska Unija - hrvatski - EMA (European Medicines Agency)

dapagliflozin viatris

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - lijekovi koji se koriste u dijabetesu - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.